These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of BCG as a live recombinant vector system: potential use as an HIV vaccine. Fuerst TR; Stover CK; de la Cruz VF Biotechnol Ther; 1991; 2(1-2):159-78. PubMed ID: 1845119 [TBL] [Abstract][Full Text] [Related]
3. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG. Dietrich G; Viret JF; Hess J Int J Med Microbiol; 2003 Feb; 292(7-8):441-51. PubMed ID: 12635927 [TBL] [Abstract][Full Text] [Related]
4. Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Aldovini A; Young RA Nature; 1991 Jun; 351(6326):479-82. PubMed ID: 2046750 [TBL] [Abstract][Full Text] [Related]
6. New use of BCG for recombinant vaccines. Stover CK; de la Cruz VF; Fuerst TR; Burlein JE; Benson LA; Bennett LT; Bansal GP; Young JF; Lee MH; Hatfull GF Nature; 1991 Jun; 351(6326):456-60. PubMed ID: 1904554 [TBL] [Abstract][Full Text] [Related]
7. Stable expression of Leptospira interrogans antigens in auxotrophic Mycobacterium bovis BCG. Seixas FK; Borsuk S; Fagundes MQ; Hartwig DD; Da Silva EF; Cerqueira GM; Dellagostin OA Biol Res; 2010; 43(1):13-8. PubMed ID: 21157628 [TBL] [Abstract][Full Text] [Related]
8. Protective immunity elicited by rBCG vaccines. Stover CK; Bansal GP; Langerman S; Hanson MS Dev Biol Stand; 1994; 82():163-70. PubMed ID: 7958471 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of cell-mediated immune response in mice by whole HIV-1 gag in Mycobacterium bovis BCG as a live vaccine candidate. Promkhatkaew D; Pinyosukhee N; Thongdeejaroen W; Sutthent R; Sawanpanyalert P; Warachit P Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):113-22. PubMed ID: 19323043 [TBL] [Abstract][Full Text] [Related]
10. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice. Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571 [TBL] [Abstract][Full Text] [Related]
11. Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations. Whelan AO; Wright DC; Chambers MA; Singh M; Hewinson RG; Vordermeier HM Vaccine; 2008 Jan; 26(2):166-73. PubMed ID: 18055073 [TBL] [Abstract][Full Text] [Related]
12. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis. Xing Z; Charters TJ Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008 [TBL] [Abstract][Full Text] [Related]
13. The immune response of the Chacma baboon to Bacille Calmette Guerin: development of a primate model for BCG-based vaccine research. Chege GK; Williamson AL; Passmore JS; Bourn W; Ryffel B; Shephard EG Vaccine; 2005 Dec; 23(50):5783-91. PubMed ID: 16214269 [TBL] [Abstract][Full Text] [Related]
14. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines. DasGupta SK; Jain S; Kaushal D; Tyagi AK Biochem Biophys Res Commun; 1998 May; 246(3):797-804. PubMed ID: 9618292 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle. Mustafa AS; Skeiky YA; Al-Attiyah R; Alderson MR; Hewinson RG; Vordermeier HM Infect Immun; 2006 Aug; 74(8):4566-72. PubMed ID: 16861643 [TBL] [Abstract][Full Text] [Related]
16. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination. Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857 [TBL] [Abstract][Full Text] [Related]
17. Protective immunity of recombinant Mycobacterium bovis BCG expressing rhomboid gene against Eimeria tenella challenge. Wang Q; Li J; Zhang X; Liu Q; Liu C; Ma G; Cao L; Gong P; Cai Y; Zhang G Vet Parasitol; 2009 Mar; 160(3-4):198-203. PubMed ID: 19117681 [TBL] [Abstract][Full Text] [Related]
18. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice. Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091 [TBL] [Abstract][Full Text] [Related]
19. Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in Mycobacterium bovis BCG. Borsuk S; Mendum TA; Fagundes MQ; Michelon M; Cunha CW; McFadden J; Dellagostin OA Tuberculosis (Edinb); 2007 Nov; 87(6):474-80. PubMed ID: 17888740 [TBL] [Abstract][Full Text] [Related]
20. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. Oettinger T; Jørgensen M; Ladefoged A; Hasløv K; Andersen P Tuber Lung Dis; 1999; 79(4):243-50. PubMed ID: 10692993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]